New study finds low mortality risk following knee and hip replacement

Jan 04, 2010

Total hip and total knee replacement surgeries are highly successful and very common procedures for people experiencing pain associated with degenerative joints. With a new hip or knee, and postoperative care prescribed by their doctors, most patients are able to regain a more active lifestyle with considerably less pain.

According to a new study published in the January 2010 issue of the (JBJS), the risk of early postoperative mortality - or death following surgery -- was slightly increased for the first 26 days after the elective surgery. The risk of mortality was estimated to be 0.1 percent.
The size of the study and the precise statistical tools used show the increase in early postoperative mortality was highest immediately after the operation. Then, 26 days after the surgery, the increased risk of death was negligible.

"Previous studies suggesting that increased mortality exists for as long as 60 or 90 days post hip or surgery may be wrong," said lead author of the study, Stein Atle Lie, PhD, MSc and professor in the Department of Surgical Sciences at the University of Bergen, Norway who led the study with colleagues from the Department of Orthopaedic Surgery, and the Norwegian Arthroplasty Register at the Haukeland University Hospital in Bergen, Norway. "We believe the risk is tied to a much shorter duration."

The study included data on 81,856 patients with a total knee replacement and 106,254 patients with a total from the Australian Orthopaedic Joint Replacement Registry and the Norwegian Arthroplasty Register. Only patients between 50 and 80 years of age with were included.

The study found the most important risk factors for increased early postoperative mortality were:

  • Male gender; and
  • Age, older than 70 years old.

"This very low postoperative mortality after hip and knee replacements should be reassuring for patients considering these surgeries," explains study co-author Lars B. Engesaeter, MD, PhD and Head of Norwegian Arthroplasty Register, Haukeland University Hospital in Bergen, Norway.

People considering hip or knee replacement should talk to their orthopaedic surgeon about any added risk in relation to their age and follow recovery guidelines closely. Other questions to consider prior to surgery can be found at www.orthoinfo.org.

"We conducted this study to help people contemplating hip or knee replacement," continues Dr. Lie. "As with all surgeries, there is some increased risk of postoperative mortality. However, we were pleased to find the rate is so minimal -- less than one percent -- following hip and knee replacements."

Explore further: Shopping for an egg donor: Is beauty, brains, or health most important?

add to favorites email to friend print save as pdf

Related Stories

'Shrug off' shoulder surgery myth, study suggests

Mar 26, 2007

Contrary to widespread belief, total surgical replacement of arthritic shoulder joints carries no greater risk of complications than replacement of other major joints, a Johns Hopkins study suggests.

HRT increases likelihood of hip and knee replacement

Oct 28, 2008

(PhysOrg.com) -- Having more children and using hormone replacement therapy (HRT) increases the likelihood that women will have joint replacement surgery, a large Oxford University-led study has shown.

How often do hip and knee replacements need revision?

Sep 02, 2008

A comprehensive study using nationwide data on hip and knee replacements in England has found that one in seventy-five patients require a revision of their joint replacement after three years. Although this compares favourably ...

Recommended for you

Using feminist theory to understand male rape

7 hours ago

Decades of feminist research have framed rape and sexual assault as a 'women's issue', leaving little room for the experiences of male victims. But a new study published in the Journal of Gender Studies suggests that feminist ...

Simulation-based training improves endoscopy execution

Oct 18, 2014

(HealthDay)—Simulation-based training (SBT) improves clinicians' performance of gastrointestinal endoscopy in both test settings and clinical practice, according to research published in the October issue ...

Data sharing in pharmaceutical industry shows progress

Oct 16, 2014

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies. Brian L. Strom, chancellor of Rutgers Biomedical and Health ...

Swiss drug maker Roche posts flat 3Q sales

Oct 16, 2014

(AP)—Swiss drugmaker Roche Holding AG has reported "stable" or flat sales for the first nine months of 2013 but says the results show strong demand for its cancer drugs and emerging new products.

User comments : 0